Chemoinformaics analysis of MENTHA-1,4,8-TRIENE
| Molecular Weight | 134.222 | nRot | 1 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 7 |
| Exact Molecular Weight | 134.11 | nRing | 1 |
| Solubility: LogS | -3.649 | nHRing | 0 |
| Solubility: LogP | 3.872 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 26.0351 |
| nHD | 0 | BPOL | 14.0449 |
| QED | 0.483 |
| Synth | 3.605 |
| Natural Product Likeliness | 2.204 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.031 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.408 |
| MDCK | 0.0000208 |
| BBB | 0.865 |
| PPB | 0.815042 |
| VDSS | 3.143 |
| FU | 0.357455 |
| CYP1A2-inh | 0.958 |
| CYP1A2-sub | 0.286 |
| CYP2c19-inh | 0.676 |
| CYP2c19-sub | 0.4 |
| CYP2c9-inh | 0.219 |
| CYP2c9-sub | 0.351 |
| CYP2d6-inh | 0.107 |
| CYP2d6-sub | 0.437 |
| CYP3a4-inh | 0.047 |
| CYP3a4-sub | 0.228 |
| CL | 15.169 |
| T12 | 0.622 |
| hERG | 0.026 |
| Ames | 0.005 |
| ROA | 0.028 |
| SkinSen | 0.959 |
| Carcinogencity | 0.829 |
| EI | 0.987 |
| Respiratory | 0.123 |
| NR-Aromatase | 0.048 |
| Antiviral | No |
| Prediction | 0.948161 |